Tachykinin Receptor: A Potential Drug Target and Biomarker (P15279)

Target Name: Tachykinin Receptor

NCBI ID: P15279

Tachykinin Receptor

Other Name(s): None

Tachykinin Receptor: A Potential Drug Target and Biomarker

Tachykininin receptors are a family of G protein-coupled receptors that play a crucial role in modulating pain perception and other physiological processes. The tachykinin receptor subfamily includes seven different subtypes, each with its own unique function and subtype distribution. Tachykinin receptors have been identified as potential drug targets in the treatment of various diseases, including pain, inflammation, and neurological disorders. This article will introduce Tachykinin Receptor (nonspecified subtype) and explore its potential as a drug target (or biomarker).

1. Tachykinin Receptor Subtypes

Tachykinin receptors are a family of G protein-coupled receptors that belong to the subfamily of muscarinic receptors. These receptors are involved in modulating various physiological processes, including pain perception, anxiety, and inflammation. The seven tachykinin receptor subtypes include:

1. Tachykinin 1R (type 1)
2. Tachykinin 1S (type 2)
3. Tachykinin 2R (type 3)
4. Tachykinin 2S (type 4)
5. Tachykinin 3R (type 5)
6. Tachykinin 3S (type 6)
7. Tachykinin 4R (type 7)

Each subtype has its own unique function and is expressed in different tissues and cells. For example, Tachykinin 1R is primarily expressed in the heart, while Tachykinin 7R is primarily expressed in the brain.

2. Tachykinin Receptor as a Drug Target

Tachykinin receptors have been identified as potential drug targets due to their involvement in pain perception and other physiological processes. The following are some of the potential benefits of targeting tachykinin receptors:

1. Pain relief: Tachykinin receptors are involved in the modulation of pain perception, making them a potential target for pain relief.
2. Inflammation: Tachykinin receptors have been shown to play a role in the regulation of inflammation, making them an attractive target for anti-inflammatory drugs.
3. Neural regulation: Tachykinin receptors are involved in the regulation of neural processes, including neurotransmitter release and neuro muscle engagement. , making them a potential target for drugs that aim to modulate neural processes.

3. Tachykinin Receptor as a Biomarker

Tachykinin receptors have also been identified as potential biomarkers for various diseases, including pain, inflammation, and neurological disorders. The following are some of the potential benefits of using tachykinin receptors as biomarkers:

1. Non-invasive: Tachykinin receptors are located in non-invasive tissues, such as skin, heart, and brain, making them an attractive target for biomarkers.
2. Sensitivity: Tachykinin receptors are known for their high sensitivity, which makes them an ideal target for biomarkers that are sensitive to small changes in the body.
3. Specificity: Tachykinin receptors have a low specificity, which makes them an attractive target for biomarkers that are specific to a particular receptor.

4. Tachykinin Receptor as a Potential Drug Target

Tachykinin receptors have been identified as potential drug targets for the treatment of various diseases, including pain, inflammation, and neurological disorders. The following are some of the potential drug targets for tachykinin receptors:

1. Pain relief: Drugs that target tachykinin receptors, such as nonsteroidal anti-inflammatory drugs (NSAIDs), have been shown to be effective in

Protein Name: Tachykinin Receptor (nonspecified Subtype)

The "Tachykinin Receptor Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Tachykinin Receptor comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets